BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Reuters
01-28
BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Jan 27 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:

  • PROCESSA PHARMACEUTICALS ANNOUNCES PRICING OF $5 MILLION PUBLIC OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

  • PROCESSA PHARMACEUTICALS INC - PURCHASE PRICE PER SHARE $0.615 FOR INSTITUTIONAL INVESTORS, $0.7975 FOR CEO AND BOARD

Source text: ID:nGNX7qXyFC

Further company coverage: PCSA.O

((Reuters.Briefs@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10